Table 2.
Study | Country | Source of Patients | Definition of Smoking | Timing of Smoking | Duration of Follow-up | Sample Size | Adjusted Estimates |
---|---|---|---|---|---|---|---|
Beaugerie 2001 [15] | France | Tertiary care | Current: >7 cigarettes/week for ≥6 months after diagnosis Former: Quit for >12 months at time of evaluation |
At colectomy or study enrolment | Mean: Current smokers: 10 years Former smokers: 16 years Never smokers: 14 years |
96a | Crudeb |
Boyko 1988 [16] | USA | HMO | Current: Smoked >100 cigarettes and continued to smoke or initiated smoking after diagnosis Former: Smoked >100 cigarettes and quit prior to diagnosis and did not restart Never: Smoked <100 cigarettes |
At diagnosis | Median (range): 8 years (1, 35) | 206 | Age; sex |
Frolkis 2016 [14] | UK | THIN database | Patient coded in EMR as Current, Former, or Never Smoker within one year of index (diagnosis date) | At diagnosis | Median (Q1, Q3): 5 years (3, 8) | 3600 | Age at diagnosis; sex; use of immunosuppressants; steroid use within 90 days of diagnosis |
Hoie 2007 [17] | Europec | Population-basedd | Current: Maintained same smoking behaviour throughout follow-up Former: Dates when patient started and stopped smoking were compared with year of disease onset and colectomy Never: Patients who had never been daily cigarette smokerse |
At diagnosis | Median (range): 10 (9, 12) years | 771 | Crude |
HMO health maintenance organization
a32 former smokers were matched with 32 current smokers and 32 never smokers
bCrude hazard ratios were estimated from Kaplan-Meier curves using the method proposed by Guyot et al.[25]
cGreece, Israel, Italy, Spain, Denmark, the Netherlands, Norway
dAdditional information on study methodology obtained from Shivananda et al.[32]
eStudy also reports a hazard ratio for patients with unknown smoking status relative to individuals who never smoked